Reich & Binstock
Free Initial Consultation Call
713-352-7883
713-352-7883

Posts tagged "#Xarelto"

Xarelto study shows drug's side effects

Nearly 2,300 federal Xarelto lawsuits are situated before a single multidistrict litigation court in the Eastern District of Louisiana. About 500 more are grouped before a mass tort state court in Philadelphia. Those are not all of the lawsuits alleging that the use of the anticoagulant led to serious, and in some cases fatal, internal bleeding. Just when the scientific evidence against Xarelto is published mainly in plaintiffs' petitions this holiday season, a national professional journal reacquaints medical science with some of the very damning findings.

Xarelto study shows drug's side effects

Nearly 2,300 federal Xarelto lawsuits are situated before a single multidistrict litigation court in the Eastern District of Louisiana. About 500 more are grouped before a mass tort state court in Philadelphia. Those are not all of the lawsuits alleging that the use of the anticoagulant led to serious, and in some cases fatal, internal bleeding. Just when the scientific evidence against Xarelto is published mainly in plaintiffs' petitions this holiday season, a national professional journal reacquaints medical science with some of the very damning findings.

Legal and scientific developments on Pradaxa, Xarelto

As wrongful death and other pharmaceutical injury lawsuits remain pending in regard to the use of two blood thinners, scientists are mercifully closing in on the development of a drug that can stop the bleeding these drugs have been known to cause. The U.S. Food and Drug Administration approved a bleeding stopper for Pradaxa (dabigatran) on Friday. Meanwhile, a drug that would reverse the anticoagulant effects of Xarelto is a little closer to market.

Legal and scientific developments on Pradaxa, Xarelto

As wrongful death and other pharmaceutical injury lawsuits remain pending in regard to the use of two blood thinners, scientists are mercifully closing in on the development of a drug that can stop the bleeding these drugs have been known to cause. The U.S. Food and Drug Administration approved a bleeding stopper for Pradaxa (dabigatran) on Friday. Meanwhile, a drug that would reverse the anticoagulant effects of Xarelto is a little closer to market.

New studies released on Xarelto bleeding

Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.

New studies released on Xarelto bleeding

Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.

Improving the way drugs are tested and marketed

Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.

Improving the way drugs are tested and marketed

Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.

Recent science addresses Xarelto bleeding risk

Two professional journal articles released during the week of June 15 underscore the reason that patients who used the anticoagulant Xarelto suffered serious injury. Those scholarly pieces also somewhat vindicated victims or the family members of decedents who have filed Xarelto lawsuits.

Recent science addresses Xarelto bleeding risk

Two professional journal articles released during the week of June 15 underscore the reason that patients who used the anticoagulant Xarelto suffered serious injury. Those scholarly pieces also somewhat vindicated victims or the family members of decedents who have filed Xarelto lawsuits.

Email Us For A Response

Contact Us For a Free Legal Consultation There is a never a fee unless we recover on your behalf.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Call for a Free Legal Consultation: 713-352-7883
Reich & Binstock - Pharmaceutical Injury & Class Action Lawyers

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Houston Law Office Map